Buscar
Mostrando ítems 1-10 de 7763
Identification of Altered Genes in Gallbladder Cancer as Potential Driver Mutations for Diagnostic and Prognostic Purposes: A Computational Approach
(SAGE, 2020)
Prognostic markers for cancer can assist in the evaluation of survival probability of patients and help clinicians to assess the available treatment modalities. Gallbladder cancer (GBC) is a rare tumor that causes 165 087 ...
Molecular analysis of the retinoblastoma (RB1) gene in acute myeloid leukemia patients
(Pergamon-elsevier Science LtdOxfordInglaterra, 1998)
Absence of significant genetic alterations in the VSX1, SOD1, TIMP3, and LOX genes in Brazilian patients with Keratoconus
(2021-01-01)
Purpose: To identify inherited or acquired mutations in the VSX1, SOD1, TIMP3 and LOX genes from the combined analysis of corneal and blood samples from patients with Keratoconus. Methods: The casuistry was consisted of ...
Penile carcinoma: Risk factors and molecular alterations
(2011-02-03)
Penile carcinoma is a rare, male cancer. Although the incidence of penile carcinoma is very low in Western countries, in some countries, the incidence is significantly greater, with penile carcinoma accounting for ≤10% of ...
Penile carcinoma: Risk factors and molecular alterations
(2011-02-03)
Penile carcinoma is a rare, male cancer. Although the incidence of penile carcinoma is very low in Western countries, in some countries, the incidence is significantly greater, with penile carcinoma accounting for ≤10% of ...
Non-myogenic tumors display altered expression of dystrophin (DMD) and a high frequency of genetic alterations
(Impact Journals LLC, 2017-01)
DMD gene mutations have been associated with the development of Dystrophinopathies. Interestingly, it has been recently reported that DMD is involved in the development and progression of myogenic tumors, assigning DMD a ...